Answers are grounded in this paper and cite their sources.
In primary- and secondary-prevention trials, statins modestly reduced the risks of non-fatal HF hospitalization and a composite of non-fatal HF hospitalization and HF death with no demonstrable difference in risk reduction between those who suffered an MI or not.
No takes yet. Share an insight, caveat, or question.
Preiss et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: